MAGI2-AS3 and central nervous system cancer: According to a study, which also examined the expression of MAGI2 antisense RNA 3(MAGI2AS3) and its clinical significance in gliomas, it was found that the expression of the lncRNA was higher in tumors than in normal samples; in glioma patients, there was a direct correlation between the MAGI2-AS3 expression and cancer world health organization (WHO) grade and The Karnofsky Performance Scale (KPS) score.